36
CPP Follow-up and Management
Figure 11. Patient Follow-up and Management After
Implantation With a CPP Device
Patients implanted
with a CPP device
Clinical follow-up in patients
with systolic HF
Device follow-up
CRT: Echo within 3–12 months
(1, B-NR)
Remote monitoring
(1, B-NR)
HBP or LBBAP: Echo within
3–12 months
(1, C-EO)
CRT: 12-lead ECG
(1, C-EO)
CRT: Multidisciplinary
management with HF and
device clinics
(2a, B-NR)
CSP: Multi-lead or 12-lead ECG
(1, B-NR)
HBP or LBBAP: Multidisciplinary
management with HF and
device clinics
(2a, C-EO)
CSP: Comprehensive assessment
at follow-up including CSP capture,
BBB correction, and thresholds
(2a, B-NR)
Continue GDMT with
recovery of LV function
(2a, C-LD)
HBP: If threshold rises >1 V, more
frequent follow-up needed
(2a, C-EO)
Routine use of thoracic impedance
alone to manage congestive HF
(3: No Benefit, B-R)
